A detailed history of Israel Englander (Millennium Management LLC) transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 47,769 shares of RMTI stock, worth $197,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,769
Holding current value
$197,285
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.45 - $1.92 $69,265 - $91,716
47,769 New
47,769 $84,000
Q2 2023

Aug 14, 2023

BUY
$1.8 - $5.46 $45,174 - $137,029
25,097 Added 56.58%
69,457 $379,000
Q1 2023

May 15, 2023

SELL
$1.03 - $2.62 $8,944 - $22,752
-8,684 Reduced 16.37%
44,360 $80,000
Q4 2022

Feb 14, 2023

BUY
$0.84 - $1.39 $17,829 - $29,502
21,225 Added 66.71%
53,044 $54,000
Q3 2022

Nov 14, 2022

SELL
$1.2 - $2.11 $19,957 - $35,091
-16,631 Reduced 34.33%
31,819 $42,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $44.1M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.